VitaNova Life Sciences (VNOV) Total Current Liabilities (2017 - 2026)
VitaNova Life Sciences (VNOV) posted Total Current Liabilities of $457975.0 for Q1 2026, up 4.55% on a QoQ basis from $438051.0 in Q4 2025, and up 115.22% year-over-year from $212789.0 in Q1 2025.
VitaNova Life Sciences (VNOV) Total Current Liabilities (2017 - 2026) Analysis & Trends
VitaNova Life Sciences' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $457975.0 for Q1 2026.
- Quarterly Total Current Liabilities rose 115.22% year-over-year to $457975.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $457975.0 (up 115.22% YoY) and the FY2025 annual result came in at $347567.0, up 153.85% from the prior year.
- Total Current Liabilities was $457975.0 for Q1 2026 at VitaNova Life Sciences, up from $438051.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $457975.0 in Q1 2026 and bottomed at $50491.0 in Q1 2022.
- A 5-year average of $178611.2 and a median of $93574.0 in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities slumped 66.74% — and 2025, when it soared 153.85%.
- VitaNova Life Sciences' Total Current Liabilities stood at $65443.0 in 2022, then soared by 40.91% to $92217.0 in 2023, then jumped by 142.84% to $223938.0 in 2024, then soared by 95.61% to $438051.0 in 2025, then increased by 4.55% to $457975.0 in 2026.
- Business Quant data shows VNOV's Total Current Liabilities at $457975.0 in Q1 2026, $438051.0 in Q4 2025, and $379975.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 67.02 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 56.13 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 41.99 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 3.30 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 8.71 Mn |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 275.45 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 1.20 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 37.51 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 457,975.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 34.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 457,975.00 |
| Oct 31, 2025 | 438,051.00 |
| Jul 31, 2025 | 379,975.00 |
| Apr 30, 2025 | 347,567.00 |
| Jan 31, 2025 | 212,789.00 |
| Oct 31, 2024 | 223,938.00 |
| Jul 31, 2024 | 199,374.00 |
| Apr 30, 2024 | 136,920.00 |
| Jan 31, 2024 | 93,574.00 |
| Oct 31, 2023 | 92,217.00 |
| Jul 31, 2023 | 83,462.00 |
| Apr 30, 2023 | 67,943.00 |
| Jan 31, 2023 | 65,843.00 |
| Oct 31, 2022 | 65,443.00 |
| Jul 31, 2022 | 62,738.00 |
| Apr 30, 2022 | 58,091.00 |
| Jan 31, 2022 | 50,491.00 |
| Oct 31, 2021 | 48,791.00 |
| Jul 31, 2021 | 32,107.00 |
| Apr 30, 2021 | 174,670.00 |